BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 8872974)

  • 21. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.
    Smit W; van den Berg N; Schouten N; Aikens E; Struijk DG; Krediet RT
    Kidney Int; 2004 Jan; 65(1):298-303. PubMed ID: 14675063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icodextrin's effects on peritoneal transport.
    Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
    Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of free water transport in peritoneal dialysis.
    Smit W; Struijk DG; Ho-Dac-Pannekeet MM; Krediet RT
    Kidney Int; 2004 Aug; 66(2):849-54. PubMed ID: 15253742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
    Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
    J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
    Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
    Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.
    Morelle J; Sow A; Fustin CA; Fillée C; Garcia-Lopez E; Lindholm B; Goffin E; Vandemaele F; Rippe B; Öberg CM; Devuyst O
    J Am Soc Nephrol; 2018 Jul; 29(7):1875-1886. PubMed ID: 29844208
    [No Abstract]   [Full Text] [Related]  

  • 27. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.
    Pannekeet MM; Imholz AL; Struijk DG; Koomen GC; Langedijk MJ; Schouten N; de Waart R; Hiralall J; Krediet RT
    Kidney Int; 1995 Sep; 48(3):866-75. PubMed ID: 7474677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
    Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
    Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal transport with icodextrin solution.
    Heimbürger O
    Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of glucose polymers on water removal and protein clearances during CAPD.
    Imholz AL; Brown CB; Koomen GC; Arisz L; Krediet RT
    Adv Perit Dial; 1993; 9():25-30. PubMed ID: 7692975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of increased dialysate fill volume on peritoneal fluid and solute transport.
    Wang T; Heimbürger O; Cheng H; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1997 Oct; 52(4):1068-76. PubMed ID: 9328947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluid and solute transport in CAPD patients using ultralow sodium dialysate.
    Imholz AL; Koomen GC; Struijk DG; Arisz L; Krediet RT
    Kidney Int; 1994 Aug; 46(2):333-40. PubMed ID: 7967344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.
    Freida P; Galach M; Divino Filho JC; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(3):267-76. PubMed ID: 17468474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.